北京科技界有头有脸的人都到了

Core Viewpoint - The article highlights the significance of the Beijing Yizhuang National Innovation Park as a key hub for technological innovation, particularly in the fields of artificial intelligence and biomedicine, showcasing prominent figures in these industries [1][5][15]. Group 1: Key Figures in Technology - The first collective learning session of the year focused on technological innovation, featuring leaders from the new generation information technology and biomedicine sectors, with over 80% involved in information technology and a significant portion in artificial intelligence [5][6]. - Notable figures include Lei Jun, CEO of Xiaomi, who emphasizes Beijing's rich talent pool and innovation environment as crucial for Xiaomi's success [8]. - Wang He, a prominent scientist and founder of Galaxy General Robotics, represents the younger generation of innovators in the AI field [8]. Group 2: Educational Initiatives - The establishment of the Zhongguancun Academy, a national-level higher education institution, aims to cultivate leading talents in artificial intelligence through an unconventional training model that integrates research and education [9]. - Liu Tieyan, the academy's first president, is recognized for his contributions to AI and previously served as the vice president of Microsoft Research Asia [9]. Group 3: Contributions to Biomedicine - Xie Xiaoliang, a biophysical chemist and director of the Beijing Changping Laboratory, is a leading figure in single-cell biology and has made significant contributions to the field [10]. - The article also highlights the work of Luo Minmin, who has made groundbreaking discoveries in neuroscience, providing new biological targets for depression treatment [13]. Group 4: Industry Developments - The article mentions the launch of Zhizhu Huazhang Technology Co., founded by Tang Jie, which focuses on large-scale pre-trained models in AI and is set to be listed on the Hong Kong Stock Exchange [12]. - The "Beijing Brain No. 1" intelligent brain-machine system developed by Luo Minmin's team has already been implanted in six patients, showcasing advancements in medical technology [14].